CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income	Treasury Stock	Non-controlling Interests
Balance, beginning of period (in shares) at Sep. 30, 2024		10,028,090
Balance, beginning of period at Sep. 30, 2024	$ 13,062	$ 5,098	$ 7,690	$ 595	$ 1,943	$ (2,286)	$ 22
Increase (Decrease) in Stockholders' Equity
Net loss	(3,126)			(3,124)			(2)
Foreign currency translation adjustments, net of taxes of $0	90				90
Share-based compensation	129		129
Issuance of common stock, net of costs (in shares)		25,444
Issuance of common stock, net of costs	0	$ 13	(13)
Balance, end of period (in shares) at Mar. 31, 2025		10,053,534
Balance, end of period at Mar. 31, 2025	10,155	$ 5,111	7,806	(2,529)	2,033	(2,286)	20
Balance, beginning of period (in shares) at Dec. 31, 2024		10,053,534
Balance, beginning of period at Dec. 31, 2024	11,305	$ 5,111	7,746	(1,322)	2,036	(2,286)	20
Increase (Decrease) in Stockholders' Equity
Net loss	(1,207)			(1,207)			0
Foreign currency translation adjustments, net of taxes of $0	(3)				(3)
Share-based compensation	60		60
Balance, end of period (in shares) at Mar. 31, 2025		10,053,534
Balance, end of period at Mar. 31, 2025	10,155	$ 5,111	7,806	(2,529)	2,033	(2,286)	20
Balance, beginning of period (in shares) at Sep. 30, 2025		10,073,534
Balance, beginning of period at Sep. 30, 2025	7,022	$ 5,121	8,039	(6,508)	2,642	(2,286)	14
Increase (Decrease) in Stockholders' Equity
Net loss	(2,528)			(2,576)			48
Foreign currency translation adjustments, net of taxes of $0	12				12
Distributions to non-controlling interests	(35)						(35)
Share-based compensation	222		222
Issuance of common stock for restricted stock unites vested (in shares)		200,932
Issuance of common stock for restricted stock units vested	0	$ 100	(100)
Issuance of common stock for services (in shares)		83,207
Issuance of common stock for services	101	$ 42	59
Issuance of common stock, net of costs (in shares)		3,147,544
Issuance of common stock, net of costs	3,365	$ 1,574	1,791
Balance, end of period (in shares) at Mar. 31, 2026		13,505,217
Balance, end of period at Mar. 31, 2026	8,159	$ 6,837	10,011	(9,084)	2,654	(2,286)	27
Balance, beginning of period (in shares) at Dec. 31, 2025		12,538,064
Balance, beginning of period at Dec. 31, 2025	8,186	$ 6,353	9,410	(7,934)	2,615	(2,286)	28
Increase (Decrease) in Stockholders' Equity
Net loss	(1,116)			(1,150)			34
Foreign currency translation adjustments, net of taxes of $0	39				39
Distributions to non-controlling interests	(35)						(35)
Share-based compensation	128		128
Issuance of common stock for restricted stock unites vested (in shares)		40,750
Issuance of common stock for restricted stock units vested	0	$ 20	(20)
Issuance of common stock, net of costs (in shares)		926,403
Issuance of common stock, net of costs	957	$ 464	493
Balance, end of period (in shares) at Mar. 31, 2026		13,505,217
Balance, end of period at Mar. 31, 2026	$ 8,159	$ 6,837	$ 10,011	$ (9,084)	$ 2,654	$ (2,286)	$ 27